GlassScriptPhysician profile
Ronald W Ingram
NPI 1609829225
$1,033.30
in general payments reported to CMS, 2019-2025
10 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.40 · 2020: $85.50 · 2021: $34.23 · 2022: $272 · 2023: $287 · 2024: $94.37 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.09 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $532.11 | 2022-2025 | Envista Envy Iol, Envista Mx60 Iol, Amvisc |
| Glaukos Corporation | $242.98 | 2020-2024 | Idose, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $79.39 | 2022-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $52.50 | 2021-2022 | |
| Allergan, INC. | $30.16 | 2021-2022 | |
| Abbvie INC. | $25.52 | 2022 | |
| Sight Sciences, INC. | $24.75 | 2023 | Omni Surgical System |
| Horizon Therapeutics Plc | $20.99 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.40 | 2019 | |
| New World Medical,INC. | $8.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.